Paul Choi

Stock Analyst at Goldman Sachs

(0)
# 4604
Out of 5,370 analysts
142
Total ratings
42.86%
Success rate
-13.28%
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
URGN UroGen Pharma
Maintains: Neutral
16 3
14.35 -79.09% 4 May 22, 2025
GOSS Gossamer Bio
Maintains: Strong Buy
7 8
1.28 525% 6 May 16, 2025
PHAT Phathom Pharmaceutic...
Maintains: Neutral
10 5
10.6 -52.83% 10 May 2, 2025
ARVN Arvinas
Maintains: Neutral
12 8
7.38 8.4% 3 May 2, 2025
XENE Xenon Pharmaceutical...
Maintains: Buy
60 52
32.07 62.15% 2 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 21
5.24 300.76% 8 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
14 12
9.14 31.29% 3 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 3
1.17 156.41% 9 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
12 10
10.18 -1.77% 4 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
20 7
13.82 -49.35% 7 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
200 225
177.69 26.63% 4 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
143
77.64 84.18% 1 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
32 42
51.79 -18.9% 7 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
85 60
33.75 77.78% 2 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 19
16.79 13.16% 6 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 32
28.37 12.8% 1 Jul 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 50
41.04 21.83% 6 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 19
4.36 335.78% 3 Jun 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
400 50
n/a n/a 7 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 26
n/a n/a 2 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 4
n/a n/a 1 Oct 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 25
1.07 2236.45% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
450 100
n/a n/a 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 4
n/a n/a 4 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 4
n/a n/a 1 Apr 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
151 170
15.15 1022.11% 2 Oct 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
225 125
n/a n/a 2 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
9 8
3.44 132.56% 4 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
132
n/a n/a 3 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
33
29.61 11.45% 1 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
112
46.87 138.96% 1 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30
n/a n/a 1 Jan 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
n/a n/a 1 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
48 49
n/a n/a 4 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
91 103
n/a n/a 2 Jul 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
135
125.3 7.74% 1 Jun 29, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
240
n/a n/a 2 Jun 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
5 22
n/a n/a 3 Apr 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
270 300
9.22 3153.8% 2 Mar 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 40
n/a n/a 3 Oct 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
60 56
n/a n/a 3 Aug 6, 2018